Biochemical markers of bone formation in the study of postmenopausal osteoporosis

被引:50
作者
Cabrera, CD
Henríquez, MS
Traba, ML
Villafañe, EA
de la Piedra, C
机构
[1] Fdn Jimenez Diaz, Serv Bioquim Clin, Lab Metab Mineral & Oseo, E-28040 Madrid, Spain
[2] Hosp Insular Canarias, Unidad Metab, Las Palmas Gran Canaria, Spain
关键词
alkaline phosphatase; aminoterminal procollagen; carboxyterminal procollagen; osteocalcin; postmenopausal osteoporosis;
D O I
10.1007/BF02672511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A comparative study was performed on the sensitivity of the determination of the available biochemical markers of bone formation - total and bone alkaline phosphatase (TAP and bAP, respectively), osteocalcin (BGP), procollagen I aminoterminal propeptide (PINP) and procollagen I carboxyterminal propeptide (PICP) - in the study of postmenopausal osteoporosis. The comparison between PINP and PICP, due to the recent development of the amino-terminal assay, is of special interest. The study included 26 untreated osteoporotic postmenopausal women, age 59 +/- 6 years (range 46-69 years) and 17 healthy control postmenopausal women, age 56 +/- 7 years (range 48-70 years). We found a significant increase in the levels of bAP (p = 0.0021), BGP (p = 0.041), PINP (p = 0.0001) and PICP (p = 0.0073), but not in the levels of TAP (p = 0.3389), in osteoporotic patients with respect to the control group. Serum PINP and bAP showed the highest diagnostic accuracy among the markers of bone formation studied, as can be deduced from the receiver operating characteristics (ROC) curves. In spite of their similar origin (amino-terminal and carboxy-terminal release from a procollagen molecule), the results obtained by measuring levels of PINP are significantly better than those found with PICP.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 19 条
  • [1] DAVIS BH, 1987, AM J PATHOL, V128, P265
  • [2] BONE GLA PROTEIN (OSTEOCALCIN) ASSAY STANDARDIZATION REPORT
    DELMAS, PD
    CHRISTIANSEN, C
    MANN, KG
    PRICE, PA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (01) : 5 - 11
  • [3] Delmas PD, 1996, INT CONGR SER, V1118, P191
  • [4] DELMAS PD, 1993, J BONE MINER RES S2, V8, P549
  • [5] DIEGO EMD, 1994, CLIN CHEM, V40, P2071
  • [6] EBELING PR, 1992, J BONE MINER RES, V7, P1243
  • [7] GARNERO P, 1994, J BONE MINER RES, V9, P255
  • [8] ASSESSMENT OF THE SERUM LEVELS OF BONE ALKALINE-PHOSPHATASE WITH A NEW IMMUNORADIOMETRIC ASSAY IN PATIENTS WITH METABOLIC BONE-DISEASE
    GARNERO, P
    DELMAS, PD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04) : 1046 - 1053
  • [9] HASLING C, 1991, J BONE MINER RES, V6, P1295
  • [10] LINKHART SG, 1993, CLIN CHEM, V39, P2254